There are more than 9 million immunocompromised people in the United States. Almost half a million of those represent a population that are moderately to severely immunocompromised and at highest risk for severe COVID-19, including stem cell and solid organ transplant patients as well as those with hematologic cancers. At Invivyd, Inc., we take those numbers very seriously and we come to work each day on a mission to deliver protection from serious viral infectious diseases, beginning with SARS-CoV-2. Invivyd deploys a proprietary integrated technology platform unique in the industry designed to assess, monitor, develop, and adapt to create best in class antibodies. In March 2024, Invivyd received emergency use authorization (EUA) from the U.S. FDA for a monoclonal antibody (mAb) in its pipeline of innovative antibody candidates. In October 2025, the FDA cleared the company's Investigational New Drug (IND) application and provided feedback to advance the company's REVOLUTION clinical program, Invivyd's development program for VYD2311, a vaccine alternative monoclonal antibody candidate for the prevention of COVID. Join an incredible team of people who thrive in a start-up environment, embrace a shared sense of ownership, have a passion for impacting patients and their families, think boldly and creatively, take targeted risks, are unafraid of failure, and welcome change as a positive catalyst to new opportunities and growth. Be part of making a difference. Be part of Invivyd. Location: New Haven, CT (Northeast preferred) Invivyd's headquarters is in New Haven, CT. This role will be hybrid with a mix of both onsite (New Haven, CT) and remote working. The Head of Clinical Operations reporting to the Head of Clinical Development will provide strategic operational guidance to ensure that clinical trials are properly planned and executed across all clinical stage programs. In addition, the incumbent will oversee all aspects of clinical trial execution, including GCP compliance on studies supporting the development of novel monoclonal antibodies aimed at preventing the transmission of and/or treating of infectious diseases, including SARS CoV-2.
Stand Out From the Crowd
Upload your resume and get instant feedback on how well it matches this job.
Job Type
Full-time
Career Level
Director
Industry
Chemical Manufacturing
Number of Employees
101-250 employees